The C3a peptide, also known as C3a anaphylatoxin, is a mediator of local inflammatory processes. It possesses antimicrobial activity. In chronic inflammation, it acts as a chemoattractant for neutrophil grnaulocytes. C3a induces smooth muscle contraction, increases vascular permeability, and causes the release of histamine from mast cells and basophilic leukocytes. C3a is a ligand for C5AR2.
C3b, once activated, can covalently bind to cell surface carbohydrates or immune aggregates via reactive thioester binding.
Mutations in the C3 gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients.
Mutations in the C3 gene induce autosomal recessive inherited C3 deficiency, and atypical hemolytic uremic syndrome. Furthermore, age-related macular degeneration is associated with C3 deficiency. Activated signaling pathways include immune response, lectin-induced complement pathway, and peptide ligand-binding receptors.